Pavaki Capital Management LLC
CIK: 2143027
Last 13F
Oct 26, 2026
Next 13F
Filed · awaiting next quarter
Options Notional
$94.37M
Holdings (132)
Q3 2026 13F, quarter ended Sep 30, 2026, filed Oct 26, 2026
- NVDA
NVIDIA CORPORATION
$29.69M
130,000 sh14.85%+400.0% - CVX
CHEVRON CORP NEW
$21.03M
103,000 sh10.52%+6.2% - INTU
INTUIT
$10.64M
38,600 sh5.32%+0.0% - B
BARRICK MNG CORP
$9.21M
226,500 sh4.61%+2.3% - QCOM
QUALCOMM INC
$9.02M
49,000 sh4.51%+0.0% - REGN
REGENERON PHARMACEUTICALS
$8.57M
11,300 sh4.29%+14.1% - MIST
MILESTONE PHARMACEUTICALS IN
$8.08M
9.34M sh4.04%+3.0% - TXT
TEXTRON INC
$6.92M
90,800 sh3.46%+7.7% - BTG
B2GOLD CORP
$6.16M
1.18M sh3.08%+0.0% - ARQT
ARCUTIS BIOTHERAPEUTICS INC
$4.94M
187,000 sh2.47%+0.0% - MU
MICRON TECHNOLOGY INC
$4.26M
4,000 sh2.13%+0.0% - CGAU
CENTERRA GOLD INC
$3.86M
177,000 sh1.93%-10.2% - NEM
NEWMONT GOLDCORP CORPORATION
$3.75M
32,500 sh1.88%+0.0% - LGND
LIGAND PHARMACEUTICALS INC
$3.47M
11,100 sh1.73%+0.0% - SLB
SCHLUMBERGER LTD
$2.97M
61,000 sh1.49%+0.0% - HRMY
HARMONY BIOSCIENCES HLDGS IN
$2.87M
73,000 sh1.43%+0.0% - SPRY
SILVERBACK THERAPEUTICS INC
$2.84M
659,600 sh1.42%+13.8% - RPRX
ROYALTY PHARMA PLC SHS
$2.57M
44,000 sh1.28%+0.0% - BIO
BIO RAD LABS INC
$2.27M
6,000 sh1.13%+0.0% - SKYD
PARAMOUNT SKYDANCE CORP COM
$2.16M
208,863 sh1.08%+0.0% - EWS
ISHARES INC MSCI SINGPOR
$2M
60,000 sh1.00%+0.0% - FSK
FS KKR CAP CORP
$1.98M
180,100 sh0.99%+12.5% - SSRM
SSR MNG INC
$1.77M
53,000 sh0.88%-29.3% - NAMS
NEWAMSTERDAM PHARMA COMPANY ORDINARY
$1.62M
66,600 sh0.81%+0.0% - DOUG
DOUGLAS ELLIMAN INC
$1.55M
1.02M sh0.78%+0.0% - HAL
HALLIBURTON CO
$1.46M
46,000 sh0.73%+0.0% - EPHE
ISHARES TR MSCI PHILIPS
$1.32M
58,000 sh0.66%+0.0% - YUMC
YUM CHINA HLDGS INC
$1.23M
30,000 sh0.62%+0.0% - KGC
KINROSS GOLD CORP
$1.19M
49,500 sh0.60%+0.0% - BIDU
BAIDU INC SPON
$1.13M
13,000 sh0.57%+0.0% - SNDX
SYNDAX PHARMACEUTICALS INC
$1.13M
60,000 sh0.56%+0.0% - OGC
OCEANAGOLD CORP
$1.11M
40,200 sh0.55%+0.0% - EQX
EQUINOX GOLD CORP
$1.01M
91,000 sh0.51%-9.0% - RMR
RMR GROUP INC
$1M
55,500 sh0.50%+56.3% - BBD
BANCO BRADESCO S A SP
$930K
264,336 sh0.47%+0.0% - UBS
UBS GROUP AG
$916K
19,000 sh0.46%+0.0% - ERIC
ERICSSON
$892K
97,500 sh0.45%+0.0% - RGLD
ROYAL GOLD INC
$885K
3,750 sh0.44%+0.0% - OSUR
ORASURE TECHNOLOGIES INC
$859K
219,033 sh0.43%+0.0% - ICLR
ICON PLC
$850K
5,000 sh0.43%+0.0% - SNY
SANOFI
$825K
20,000 sh0.41%+0.0% - BKR
BAKER HUGHES COMPANY
$824K
15,000 sh0.41%+0.0% - KSPI
KASPI KZ JSC
$818K
8,700 sh0.41%+0.0% - BIIB
BIOGEN INC
$791K
3,500 sh0.40%+0.0% - MRK
MERCK & CO INC
$727K
5,000 sh0.36%+0.0% - LNTH
LANTHEUS HLDGS INC
$707K
7,100 sh0.35%+0.0% - KBR
KBR INC
$703K
20,000 sh0.35%+0.0% - ITUB
ITAU UNIBANCO HLDG SA SPON
$703K
82,400 sh0.35%+0.0% - CLBT
CELLEBRITE DI LTD ORDINARY
$676K
60,000 sh0.34%+0.0% - DHC
DIVERSIFIED HEALTHCARE TR
$667K
85,000 sh0.33%+0.0%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
 NVDA NVIDIA CORPORATION | 130,000 | $29.69M | +400.0% | 14.85% | Q3 2026 |
 CVX CHEVRON CORP NEW | 103,000 | $21.03M | +6.2% | 10.52% | Q3 2026 |
 INTU INTUIT | 38,600 | $10.64M | +0.0% | 5.32% | Q3 2026 |
 B BARRICK MNG CORP | 226,500 | $9.21M | +2.3% | 4.61% | Q3 2026 |
 QCOM QUALCOMM INC | 49,000 | $9.02M | +0.0% | 4.51% | Q3 2026 |
 REGN REGENERON PHARMACEUTICALS | 11,300 | $8.57M | +14.1% | 4.29% | Q3 2026 |
 MIST MILESTONE PHARMACEUTICALS IN | 9.34M | $8.08M | +3.0% | 4.04% | Q3 2026 |
 TXT TEXTRON INC | 90,800 | $6.92M | +7.7% | 3.46% | Q3 2026 |
 BTG B2GOLD CORP | 1.18M | $6.16M | +0.0% | 3.08% | Q3 2026 |
 ARQT ARCUTIS BIOTHERAPEUTICS INC | 187,000 | $4.94M | +0.0% | 2.47% | Q3 2026 |
 MU MICRON TECHNOLOGY INC | 4,000 | $4.26M | +0.0% | 2.13% | Q3 2026 |
 CGAU CENTERRA GOLD INC | 177,000 | $3.86M | -10.2% | 1.93% | Q3 2026 |
 NEM NEWMONT GOLDCORP CORPORATION | 32,500 | $3.75M | +0.0% | 1.88% | Q3 2026 |
 LGND LIGAND PHARMACEUTICALS INC | 11,100 | $3.47M | +0.0% | 1.73% | Q3 2026 |
 SLB SCHLUMBERGER LTD | 61,000 | $2.97M | +0.0% | 1.49% | Q3 2026 |
 HRMY HARMONY BIOSCIENCES HLDGS IN | 73,000 | $2.87M | +0.0% | 1.43% | Q3 2026 |
 SPRY SILVERBACK THERAPEUTICS INC | 659,600 | $2.84M | +13.8% | 1.42% | Q3 2026 |
 RPRX ROYALTY PHARMA PLC SHS | 44,000 | $2.57M | +0.0% | 1.28% | Q3 2026 |
 BIO BIO RAD LABS INC | 6,000 | $2.27M | +0.0% | 1.13% | Q3 2026 |
 SKYD PARAMOUNT SKYDANCE CORP COM | 208,863 | $2.16M | +0.0% | 1.08% | Q3 2026 |
 EWS ISHARES INC MSCI SINGPOR | 60,000 | $2M | +0.0% | 1.00% | Q3 2026 |
 FSK FS KKR CAP CORP | 180,100 | $1.98M | +12.5% | 0.99% | Q3 2026 |
 SSRM SSR MNG INC | 53,000 | $1.77M | -29.3% | 0.88% | Q3 2026 |
 NAMS NEWAMSTERDAM PHARMA COMPANY ORDINARY | 66,600 | $1.62M | +0.0% | 0.81% | Q3 2026 |
 DOUG DOUGLAS ELLIMAN INC | 1.02M | $1.55M | +0.0% | 0.78% | Q3 2026 |
 HAL HALLIBURTON CO | 46,000 | $1.46M | +0.0% | 0.73% | Q3 2026 |
 EPHE ISHARES TR MSCI PHILIPS | 58,000 | $1.32M | +0.0% | 0.66% | Q3 2026 |
 YUMC YUM CHINA HLDGS INC | 30,000 | $1.23M | +0.0% | 0.62% | Q3 2026 |
 KGC KINROSS GOLD CORP | 49,500 | $1.19M | +0.0% | 0.60% | Q3 2026 |
 BIDU BAIDU INC SPON | 13,000 | $1.13M | +0.0% | 0.57% | Q3 2026 |
 SNDX SYNDAX PHARMACEUTICALS INC | 60,000 | $1.13M | +0.0% | 0.56% | Q3 2026 |
 OGC OCEANAGOLD CORP | 40,200 | $1.11M | +0.0% | 0.55% | Q3 2026 |
 EQX EQUINOX GOLD CORP | 91,000 | $1.01M | -9.0% | 0.51% | Q3 2026 |
 RMR RMR GROUP INC | 55,500 | $1M | +56.3% | 0.50% | Q3 2026 |
 BBD BANCO BRADESCO S A SP | 264,336 | $930K | +0.0% | 0.47% | Q3 2026 |
 UBS UBS GROUP AG | 19,000 | $916K | +0.0% | 0.46% | Q3 2026 |
 ERIC ERICSSON | 97,500 | $892K | +0.0% | 0.45% | Q3 2026 |
 RGLD ROYAL GOLD INC | 3,750 | $885K | +0.0% | 0.44% | Q3 2026 |
 OSUR ORASURE TECHNOLOGIES INC | 219,033 | $859K | +0.0% | 0.43% | Q3 2026 |
 ICLR ICON PLC | 5,000 | $850K | +0.0% | 0.43% | Q3 2026 |
 SNY SANOFI | 20,000 | $825K | +0.0% | 0.41% | Q3 2026 |
 BKR BAKER HUGHES COMPANY | 15,000 | $824K | +0.0% | 0.41% | Q3 2026 |
 KSPI KASPI KZ JSC | 8,700 | $818K | +0.0% | 0.41% | Q3 2026 |
 BIIB BIOGEN INC | 3,500 | $791K | +0.0% | 0.40% | Q3 2026 |
 MRK MERCK & CO INC | 5,000 | $727K | +0.0% | 0.36% | Q3 2026 |
 LNTH LANTHEUS HLDGS INC | 7,100 | $707K | +0.0% | 0.35% | Q3 2026 |
 KBR KBR INC | 20,000 | $703K | +0.0% | 0.35% | Q3 2026 |
 ITUB ITAU UNIBANCO HLDG SA SPON | 82,400 | $703K | +0.0% | 0.35% | Q3 2026 |
 CLBT CELLEBRITE DI LTD ORDINARY | 60,000 | $676K | +0.0% | 0.34% | Q3 2026 |
 DHC DIVERSIFIED HEALTHCARE TR | 85,000 | $667K | +0.0% | 0.33% | Q3 2026 |
1-50 of 132 holdings
Derivatives (30)
PUT + CALL positions. Value is notional exposure of the underlying, not capital deployed.
- CVNACall
CARVANA CO
$37.84M
605,000 sh40.09%+0.0% - TSLACall
TESLA MTRS INC
$15.79M
44,500 sh16.73%+2.3% - PLTRCall
PALANTIR TECHNOLOGIES INC
$9.45M
50,500 sh10.01%+0.0% - QQQPut
INVESCO QQQ TR
$5.18M
7,000 sh5.49%-69.6% - QQQCall
INVESCO QQQ TR
$3.33M
4,500 sh3.53%+0.0% - AVGOCall
BROADCOM INC
$2.46M
7,000 sh2.61%+0.0% - CRMCall
SALESFORCE INC
$1.84M
8,000 sh1.95%+0.0% - APPCall
APPLOVIN CORP COM
$1.8M
6,200 sh1.91%+0.0% - PLTRPut
PALANTIR TECHNOLOGIES INC
$1.68M
9,000 sh1.78%+0.0% - QQQMPut
INVESCO EXCH TRADED FD TR II NASDAQ 100
$1.68M
5,500 sh1.78%-21.4%
| Security | Type | Shares | Notional | Change | % of Book | Period |
|---|---|---|---|---|---|---|
 CVNA CARVANA CO | Call | 605,000 | $37.84M | +0.0% | 40.09% | Q3 2026 |
 TSLA TESLA MTRS INC | Call | 44,500 | $15.79M | +2.3% | 16.73% | Q3 2026 |
 PLTR PALANTIR TECHNOLOGIES INC | Call | 50,500 | $9.45M | +0.0% | 10.01% | Q3 2026 |
 QQQ INVESCO QQQ TR | Put | 7,000 | $5.18M | -69.6% | 5.49% | Q3 2026 |
QQQ INVESCO QQQ TR | Call | 4,500 | $3.33M | +0.0% | 3.53% | Q3 2026 |
 AVGO BROADCOM INC | Call | 7,000 | $2.46M | +0.0% | 2.61% | Q3 2026 |
 CRM SALESFORCE INC | Call | 8,000 | $1.84M | +0.0% | 1.95% | Q3 2026 |
 APP APPLOVIN CORP COM | Call | 6,200 | $1.8M | +0.0% | 1.91% | Q3 2026 |
PLTR PALANTIR TECHNOLOGIES INC | Put | 9,000 | $1.68M | +0.0% | 1.78% | Q3 2026 |
 QQQM INVESCO EXCH TRADED FD TR II NASDAQ 100 | Put | 5,500 | $1.68M | -21.4% | 1.78% | Q3 2026 |
1-10 of 30 derivatives
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
About Pavaki Capital Management LLC
Pavaki Capital Management LLC is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 2143027). Signal8 holds 29 13F filings from it. Its SEC filings list Colorado as its state of incorporation.
Its most recent 13F holdings report covers Q3 2026 (the quarter ended Sep 30, 2026) and was filed on Oct 26, 2026. That report lists 132 securities, not counting options, the same number as in Q2 2026.
Its five largest reported positions, in order, are NVIDIA CORPORATION (NVDA), CHEVRON CORP NEW (CVX), INTUIT (INTU), BARRICK MNG CORP (B) and QUALCOMM INC (QCOM). The next five are REGENERON PHARMACEUTICALS (REGN), MILESTONE PHARMACEUTICALS IN (MIST), TEXTRON INC (TXT), B2GOLD CORP (BTG) and ARCUTIS BIOTHERAPEUTICS INC (ARQT).
Recent 13F filings by Pavaki Capital Management LLC
- Q3 2026: 13F-HR filed Oct 26, 2026, listing 132 securities.
- Q2 2026: 13F-HR filed Aug 7, 2026, listing 132 securities.
- Q1 2026: 13F-HR filed Aug 7, 2026, listing 121 securities.
- Q4 2025: 13F-HR/A filed Aug 7, 2026, listing 95 securities.
- Q4 2025: 13F-HR filed Aug 7, 2026, listing 82 securities.